StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.44+0.02 (+0.45%)

Close on Nov 17, 2026Market cap $288.75MP/E –Yield –

Treace Medical Concepts total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Treace Medical Concepts's total debt was $59.21M at Jun 30, 2026. For fiscal 2025 it was $57.33M, up 7.5% from the year before. The highest annual figure on record is $57.33M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$57.33M+7.5%
FY2024Dec 31, 2024$53.31M+0.6%
FY2023Dec 31, 2023$53.01M+0.6%
FY2022Dec 31, 2022$52.71M+79.5%
FY2021Dec 31, 2021$29.37M-5.2%
FY2020Dec 31, 2020$30.98M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$59.21M+8.5%
Q1 FY2026Mar 31, 2026$57.60M+7.8%
Q4 FY2025Dec 31, 2025$57.33M+7.5%
Q3 FY2025Sep 30, 2025$55.33M+3.9%
Q2 FY2025Jun 30, 2025$54.57M+2.7%
Q1 FY2025Mar 31, 2025$53.43M+0.6%
Q4 FY2024Dec 31, 2024$53.31M+0.6%
Q3 FY2024Sep 30, 2024$53.23M+0.6%
Q2 FY2024Jun 30, 2024$53.16M+0.6%
Q1 FY2024Mar 31, 2024$53.08M+0.6%
Q4 FY2023Dec 31, 2023$53.01M+0.6%
Q3 FY2023Sep 30, 2023$52.93M+0.6%
Q2 FY2023Jun 30, 2023$52.86M+0.6%
Q1 FY2023Mar 31, 2023$52.79M+79.5%
Q4 FY2022Dec 31, 2022$52.71M+79.5%
Q3 FY2022Sep 30, 2022$52.64M+79.5%
Q2 FY2022Jun 30, 2022$52.56M+79.5%
Q1 FY2022Mar 31, 2022$29.41M+0.6%
Q4 FY2021Dec 31, 2021$29.37M-5.2%
Q3 FY2021Sep 30, 2021$29.32M–
Q2 FY2021Jun 30, 2021$29.28M–
Q1 FY2021Mar 31, 2021$29.23M–
Q4 FY2020Dec 31, 2020$30.98M–

More Treace Medical Concepts figures

See a number that looks wrong?